These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22531025)

  • 1. A study of 46 patients with acquired haemophilia A in Taiwan finds elevated LDH level and mucosal bleedings associated with reduced response to immunosuppressive therapy.
    Huang SY; Tsay W; Lin HY; Hsu SC; Shen MC
    Haemophilia; 2012 May; 18(3):e71-2. PubMed ID: 22531025
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab in the treatment of acquired factor VIII inhibitors.
    Onitilo AA; Skorupa A; Lal A; Ronish E; Mercier RJ; Islam R; Lazarchick J
    Thromb Haemost; 2006 Jul; 96(1):84-7. PubMed ID: 16807656
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone.
    Hertzberg MS; Favaloro E; Koutts J
    Am J Hematol; 2002 Aug; 70(4):330-1. PubMed ID: 12210817
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies.
    Petrovic M; Derom E; Baele G
    Haematologica; 2000 Aug; 85(8):895-6. PubMed ID: 10942956
    [No Abstract]   [Full Text] [Related]  

  • 5. Acquired hemophilia.
    Bouvry P; Recloux P
    Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prophylaxis treatment versus on-demand treatment for patients with severe haemophilia A: comparisons of cost and outcomes in Taiwan.
    Liou WS; Tu TC; Cheng SN; Chou TY; Lee CF; Lin TK; Chung MI; Cham TM
    Haemophilia; 2011 Jan; 17(1):45-54. PubMed ID: 20722742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
    Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acquired factor VIIIc inhibitors. Two cases and a review of the literature].
    Bayani N; Lelong F
    Ann Med Interne (Paris); 2001 Apr; 152(3):201-8. PubMed ID: 11431582
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquired haemophilia A: successful treatment with immunosuppression, methylprednisolone pulses and oral cyclosporin.
    Pardos-Gea J; Ordi-Ros J; Altisent C; Balada E; Pérez-López J; Vilardell M
    Thromb Haemost; 2006 Apr; 95(4):735-7. PubMed ID: 16601847
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab as first-line therapy for acquired haemophilia A: a single-centre 10-year experience.
    Rossi B; Blanche P; Roussel-Robert V; Berezné A; Combe S; Coppo P; Guillevin L; Le Jeunne C; Mouthon L; Ounnoughene N; Stieltjes N; Groh M
    Haemophilia; 2016 Jul; 22(4):e338-41. PubMed ID: 27329210
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acquired factor VIII deficiency treated with cyclosporine].
    Leinøe EB; Jørgensen M; Nielsen JD
    Ugeskr Laeger; 1999 Aug; 161(34):4762-3. PubMed ID: 10500467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment.
    Hauser I; Schneider B; Lechner K
    Thromb Haemost; 1995 Jan; 73(1):1-5. PubMed ID: 7740477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to factor VIII in hemophilia A patients.
    Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J
    Vox Sang; 2000; 78 Suppl 2():187-90. PubMed ID: 10938950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety evaluation of sucrose-formulated recombinant factor VIII for Taiwanese patients with haemophilia A.
    Young JH; Liu HC; Hsueh EJ; Huang ML; Peng CT; Chen RL; Maas-Enriquez M; Achilles K
    Haemophilia; 2009 Jul; 15(4):968-70. PubMed ID: 19473407
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment and outcome of acquired haemophilia A with a standard conventional regimen in a cohort without associated conditions.
    Ng HJ; Tan DC; Lee LH
    Haemophilia; 2006 Jul; 12(4):423-8. PubMed ID: 16834745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Macrohaematuria post-partum: an unusual case of acquired haemophilia after pregnancy].
    Prencipe MA; D'Errico M; Di Giorgio G; Gatta G; Gesuete A; Nobile M; Stallone C
    G Ital Nefrol; 2002; 19(2):204-8. PubMed ID: 12195420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.
    Hay CR; Ludlam CA; Colvin BT; Hill FG; Preston FE; Wasseem N; Bagnall R; Peake IR; Berntorp E; Mauser Bunschoten EP; Fijnvandraat K; Kasper CK; White G; Santagostino E
    Thromb Haemost; 1998 Apr; 79(4):762-6. PubMed ID: 9569189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
    Kessler CM; Ludlam CA
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
    Field JJ; Fenske TS; Blinder MA
    Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of acquired factor VIII inhibitors.
    Barnett B; Kruse-Jarres R; Leissinger CA
    Curr Opin Hematol; 2008 Sep; 15(5):451-5. PubMed ID: 18695367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.